Sterling
Novo Nordisk logo
Novo Nordisk
Viking Therapeutics logo
Viking Therapeutics

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Novo Nordisk 12.087, Viking Therapeutics 0.

Novo Nordisk vs Viking Therapeutics Net Worth and Market Cap

Novo Nordisk (NVO) and Viking Therapeutics (VKTX) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $0 for Viking Therapeutics. Novo Nordisk leads on revenue.

Key differences

  • Novo Nordisk's KPIs on Sterling include Next-Generation Obesity: CagriSema + Amycretin Readouts and 2030 Ambitions (Capital Markets Day, 21 Sep 2026).
  • Viking Therapeutics's KPIs on Sterling include Cash + Short-Term Investments (Quarterly) and Viking Oral VK2735 Phase 3 Timing.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Viking Therapeutics.
MetricNovo NordiskViking Therapeutics
Market Cap--
Revenue$12.09B$0
Cost of Revenue$2.63B$0
Gross Profit$9.45B$0
Operating Income$4.17B$-164.00M
Net Income$3.23B$-158.00M
R&D Expense$2.74B$150.00M
Earnings Per Share$0.73-$1.37
Gross Margin78.2%-
Operating Margin34.5%-
Net Profit Margin26.7%-
Free Cash Flow$6.53B$-114.00M
Cumulative Free Cash Flow$107.39B$-747.00M
Operating Cash Flow$8.50B$-114.00M
Cash & Equivalents$6.85B$118.00M

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites